Skip to content
OpenCapital
Get started

Alumis Inc. ALMS Business Segments — Research And Development Personnel Related Costs

Similar metrics at other companies

ArriVent BioPharma, Inc. logo
AVBPSingle Reportable — Research And Development Expense Personnel Related And Other Internal Costs
$10.23M+70.3%
Ocular Therapeutix logo
OCULSingle Reportable — Research And Development Unallocated Expenses Personnel Costs
$12.98M+44.5%
Capricor Therapeutics logo
CAPRSingle Reportable — Research And Development Expense Share Based Compensation Expense
$3.13M+14.2%
Rapport Therapeutics, Inc. logo
RAPPResearch And Development Personnel Related Costs Including Stock-Based Compensation — Research And Development Expense
$10.64M+56.8%
Vertex, Inc. logo
VERXSingle Reportable — Research And Development Expense
$24.55M+17.5%
Crinetics Pharmaceuticals logo
CRNXReportable Segment — Research And Development Personnel Expenses
$30.65M+19.6%

Other financials

Income statement

See full
Revenue$1.7M-90.0%
Operating income-$98.4M+3.1%
Net income-$93.1M+6.0%
EPS (diluted)-$0.74+59.3%

Balance sheet

See full
Cash & equivalents$63.9M-50.3%
Total debt$35.7M+1,881%
Total equity$567.0M+237%
Total assets$671.6M+157%

Cash flow

See full
Operating cash flow-$87.1M-8.4%
CapEx$164.0K+343%
Free cash flow-$87.2M-8.5%

Valuation

See full
Market cap$3.12B+739%
Enterprise value$3.1B+1,238%
P/S371.9×—

Profitability

See full
Operating margin-5,364%—
Net margin-2,825.7%—
FCF margin-4,487.4%—

Returns & leverage

See full
Return on equity-64.6%—
Debt / equity0.1×+0.1×
Current ratio7.5×+3.8×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept alms:ResearchAndDevelopmentPersonnelRelatedCosts.

The official record: Alumis Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alumis Inc.'s business segments — research and development personnel related costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alumis Inc.'s business segments — research and development personnel related costs?
Alumis Inc. (ALMS) reported business segments — research and development personnel related costs of $26.07M in Q1 2026.
How has Alumis Inc.'s business segments — research and development personnel related costs changed year-over-year?
Alumis Inc.'s business segments — research and development personnel related costs increased by 47.6% year-over-year, from $17.66M to $26.07M.
What is the long-term trend for Alumis Inc.'s business segments — research and development personnel related costs?
Over 2 years (2023 to 2025), Alumis Inc.'s business segments — research and development personnel related costs has grown at a 70.0% compound annual growth rate (CAGR), from $32.07M to $92.7M.
What does business segments — research and development personnel related costs mean?
Reflects the total compensation, benefits, and stock-based compensation expenses for employees dedicated to research and development activities. It serves as a proxy for the company's investment in internal human capital and scientific talent.